Trial Profile
Clinical Trials Insight: 700056051
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 10 May 2010
Price :
$35
*
At a glance
- Drugs Alpha galactosylceramide (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions
- Sponsors REGiMMUNE
- 10 May 2010 New trial record.